Hikma Pharmaceutical | HIK - Operating Profit


Hikma Pharmaceutical reported $348M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Almirall EUR 71.55M 41.32M Jun/2026
argenx SE USD 493M 99M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Bayer EUR 827M 2.7B Jun/2026
Fresenius EUR 719M 118M Jun/2026
Genmab DKK 407M 182M Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Orion EUR 176.6M 61.8M Jun/2026
Recordati EUR 203.76M 27.35M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
UCB EUR 1.29B 571M Dec/2025